Protective Effects of GLP-1 on Glomerular Endothelium and Its Inhibition by PKCβ Activation in Diabetes

To characterize glucagon-like peptide (GLP)-1 signaling and its effect on renal endothelial dysfunction and glomerulopathy. We studied the expression and signaling of GLP-1 receptor (GLP-1R) on glomerular endothelial cells and the novel finding of protein kinase A–dependent phosphorylation of c-Raf at Ser259 and its inhibition of angiotensin II (Ang II) phospho–c-Raf(Ser338) and Erk1/2 phosphorylation. Mice overexpressing protein kinase C (PKC)β2 in endothelial cells (EC-PKCβ2Tg) were established. Ang II and GLP-1 actions in glomerular endothelial cells were analyzed with small interfering RNA of GLP-1R. PKCβ isoform activation induced by diabetes decreased GLP-1R expression and protective action on the renal endothelium by increasing its degradation via ubiquitination and enhancing phospho–c-Raf(Ser338) and Ang II activation of phospho-Erk1/2. EC-PKCβ2Tg mice exhibited decreased GLP-1R expression and increased phospho–c-Raf(Ser338), leading to enhanced effects of Ang II. Diabetic EC-PKCβ2Tg mice exhibited greater loss of endothelial GLP-1R expression and exendin-4–protective actions and exhibited more albuminuria and mesangial expansion than diabetic controls. These results showed that the renal protective effects of GLP-1 were mediated via the inhibition of Ang II actions on cRaf(Ser259) and diminished by diabetes because of PKCβ activation and the increased degradation of GLP-1R in the glomerular endothelial cells.

[1]  M. Donohue,et al.  Pirfenidone for diabetic nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[2]  G. King,et al.  Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity. , 2011, Kidney international.

[3]  B. Croker,et al.  Endothelial dysfunction as a potential contributor in diabetic nephropathy , 2011, Nature Reviews Nephrology.

[4]  S. Miyamoto,et al.  Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes , 2011, Diabetologia.

[5]  J. Thurman,et al.  The role of endothelial cell injury in thrombotic microangiopathy. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  Å. Sjöholm,et al.  Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor , 2010, Molecular and Cellular Endocrinology.

[7]  A. Nishiyama,et al.  Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model. , 2009, Biochemical and biophysical research communications.

[8]  A. Newton,et al.  The life and death of protein kinase C. , 2008, Current drug targets.

[9]  D. Mochly‐Rosen,et al.  Alteration of gene expression during progression of hypertension-induced cardiac dysfunction in rats. , 2008, American journal of physiology. Heart and circulatory physiology.

[10]  Jie Zhou,et al.  Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets. , 2007, American journal of physiology. Endocrinology and metabolism.

[11]  J. Lim,et al.  Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice. , 2007, Journal of the American Society of Nephrology : JASN.

[12]  B. Croker,et al.  Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. , 2007, Journal of the American Society of Nephrology : JASN.

[13]  D. Drucker.  The biology of incretin hormones. , 2006, Cell metabolism.

[14]  B. Neel,et al.  Stops along the RAS pathway in human genetic disease , 2006, Nature Medicine.

[15]  A. Goldfine,et al.  Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance. , 2006, Diabetes.

[16]  D. Levy,et al.  Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study). , 2005, The American journal of cardiology.

[17]  Akiyoshi Uemura,et al.  High level of endothelial cell-specific gene expression by a combination of the 5' flanking region and the 5' half of the first intron of the VE-cadherin gene. , 2005, Blood.

[18]  W. Hsueh,et al.  Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy. , 2005, Kidney international.

[19]  C. Betsholtz,et al.  A new method for large scale isolation of kidney glomeruli from mice. , 2002, The American journal of pathology.

[20]  C. Marcantoni,et al.  Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy. , 2002, Kidney international.

[21]  W. Kolch,et al.  Cyclic AMP-Dependent Kinase Regulates Raf-1 Kinase Mainly by Phosphorylation of Serine 259 , 2002, Molecular and Cellular Biology.

[22]  R. Evans,et al.  Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. White,et al.  Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. , 1999, The Journal of clinical investigation.

[24]  L. Cantley,et al.  Conditional Inhibition of the Mitogen-activated Protein Kinase Cascade by Wortmannin , 1997, The Journal of Biological Chemistry.

[25]  J. Habener,et al.  Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. , 1996, Endocrinology.

[26]  K. Catt,et al.  Angiotensin receptors and their antagonists. , 1996, The New England journal of medicine.

[27]  L. Aiello,et al.  Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. , 1995, The Journal of clinical investigation.

[28]  G. Franzoso,et al.  Structure, regulation and function of NF-kappa B. , 1994, Annual review of cell biology.

[29]  S. Cook,et al.  Inhibition by cAMP of Ras-dependent activation of Raf. , 1993, Science.

[30]  R. Tsien,et al.  Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A , 1993, Molecular and cellular biology.